[HTML][HTML] Current landscape of therapeutic EUS: Changing paradigms in gastroenterology practice
Therapeutic EUS has witnessed exponential growth in the last decade, but it has been
considered investigational until recently. An increasing body of good-quality evidence is …
considered investigational until recently. An increasing body of good-quality evidence is …
Lumen-apposing metal stents (with videos)
RJ Law, V Chandrasekhara, A Bhatt, JC Bucobo… - Gastrointestinal …, 2021 - Elsevier
Background and Aims Lumen-apposing metal stents (LAMSs) are a novel class of devices
that have expanded the spectrum of endoscopic GI interventions. LAMSs with their dumbbell …
that have expanded the spectrum of endoscopic GI interventions. LAMSs with their dumbbell …
Endoscopic ultrasound-guided biliary drainage of first intent with a lumen-apposing metal stent vs endoscopic retrograde cholangiopancreatography in malignant …
Background & Aims Endoscopic ultrasound–guided choledochoduodenostomy with a lumen-
apposing metal stent (EUS-CDS) is a promising modality for management of malignant …
apposing metal stent (EUS-CDS) is a promising modality for management of malignant …
Comparison of EUS-guided choledochoduodenostomy and percutaneous drainage for distal biliary obstruction: A multicenter cohort study
T Sawas, NJ Bailey, KYKA Yeung… - Endoscopic …, 2022 - journals.lww.com
Methods: A multicenter retrospective cohort study from three different centers was
performed. Cox regression was used to compare time to reintervention and survival and …
performed. Cox regression was used to compare time to reintervention and survival and …
Reduction of LAMS-related adverse events with accumulating experience in a large-volume tertiary referral center
S Stefanovic, H Degroote, P Hindryckx - Journal of clinical medicine, 2023 - mdpi.com
Background and aims: Lumen-apposing metal stents (LAMSs) are increasingly used both for
on-and off-label indications. We continuously adapt our step-by-step protocol to optimize the …
on-and off-label indications. We continuously adapt our step-by-step protocol to optimize the …
[HTML][HTML] Endoscopic ultrasound-guided biliary drainage-current status and future perspectives
PI Karagyozov, I Tishkov, I Boeva… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Endoscopic retrograde cholangiopancreatography (ERCP) with stenting is the treatment
modality of choice for patients with benign and malignant bile duct obstruction. ERCP could …
modality of choice for patients with benign and malignant bile duct obstruction. ERCP could …
[HTML][HTML] Advances in the endoscopic management of malignant biliary obstruction
T Thomaidis, G Kallimanis, G May, P Zhou… - Annals of …, 2020 - ncbi.nlm.nih.gov
Biliary obstruction is common in pancreatobiliary malignancies and has a negative impact
on the patient's quality of life, postoperative complications, and survival rates. Particularly in …
on the patient's quality of life, postoperative complications, and survival rates. Particularly in …
EUS-guided biliary drainage in malignant distal biliary obstruction: An international survey to identify barriers of technology implementation
Methods: An online survey was generated using Google Forms. Six gastroenterology/
endoscopy associations were contacted between July 2019 and November 2019. Survey …
endoscopy associations were contacted between July 2019 and November 2019. Survey …
Lumen-apposing metal stents in 2024: troubleshooting and managing common and uncommon adverse events
A Tyberg, K Binmoeller, T Kowalski - Gastrointestinal Endoscopy, 2024 - giejournal.org
The emergence of lumen-apposing metal stents (LAMSs) has revolutionized the field of
advanced endoscopy and spearheaded the emergence of the subspecialty of therapeutic …
advanced endoscopy and spearheaded the emergence of the subspecialty of therapeutic …
Safety and efficacy of endoscopic retrograde cholangiopancreatography in previously treated liver cancer patients: a survival analysis
HY Li, L Jia, W Du, XR Huang - Frontiers in Oncology, 2023 - frontiersin.org
Background and Aim The prognosis and medication response for liver malignancies are
both dismal and highly heterogeneous. For this diverse malignancy, multimodality therapies …
both dismal and highly heterogeneous. For this diverse malignancy, multimodality therapies …